Molecular Markers for Breast Cancer: Prediction on Tumor BehaviorBruna Karina Banin Hirata, Maria Angélica Ehara Watanabe, Julie Massayo Maeda Oda et al.|Disease Markers|2014Cited by 185
CC Chemokine Receptor 5: The Interface of Host Immunity and CancerCarlos Eduardo Coral de Oliveira, Maria Angélica Ehara Watanabe, Bruna Karina Banin Hirata et al.|Disease Markers|2014Cited by 65
Role of CXCL12 and CXCR4 in normal cerebellar development and medulloblastomaPatricia Midori Murobushi Ozawa, Maria Angélica Ehara Watanabe, Julie Massayo Maeda Oda et al.|International Journal of Cancer|2014Cited by 36
<i>FOXP3 Transcription Factor</i>: A Candidate Marker for Susceptibility and Prognosis in Triple Negative Breast CancerLeandra Fiori Lopes, Maria Angélica Ehara Watanabe, Alda Losi Guembarovski et al.|BioMed Research International|2014Cited by 27
CXCL12 and TP53 genetic polymorphisms as markers of susceptibility in a Brazilian children population with acute lymphoblastic leukemia (ALL)Aparecida de Lourdes Perim, Maria Angélica Ehara Watanabe, Karen Brajão de Oliveira et al.|Molecular Biology Reports|2013Cited by 24